The tumor-necrosis-factor-associated periodic syndrome, the brain, and tumor-necrosis-factor-alpha antagonists

Neurology. 2007 May 15;68(20):1742-4. doi: 10.1212/01.wnl.0000260226.21010.2b. Epub 2007 Mar 14.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amino Acid Substitution
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Autoimmune Diseases of the Nervous System / diagnosis
  • Autoimmune Diseases of the Nervous System / drug therapy*
  • Autoimmune Diseases of the Nervous System / etiology
  • Autoimmune Diseases of the Nervous System / genetics
  • Brain / immunology*
  • Brain / pathology
  • Diagnosis, Differential
  • Encephalomyelitis, Acute Disseminated / diagnosis
  • Etanercept
  • Exanthema / etiology
  • Exons / genetics
  • Fever / etiology
  • Genes, Dominant
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Male
  • Mutation, Missense
  • Pain / etiology
  • Periodicity
  • Point Mutation
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Receptors, Tumor Necrosis Factor, Type I / genetics*
  • Syndrome
  • T-Lymphocytes, Cytotoxic / pathology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Receptors, Tumor Necrosis Factor, Type I
  • TNFRSF1A protein, human
  • Tumor Necrosis Factor-alpha
  • Etanercept